Results 71 to 80 of about 7,418 (172)
The leishmaniases are a collection of vector-borne parasitic diseases caused by a number of different Leishmania species that are distributed worldwide.
Beatriz Coutinho De Oliveira +2 more
doaj +1 more source
Background and Aims Cutaneous leishmaniasis (CL) represents the most common form of leishmaniasis. It imposes a significant medical burden due to long‐lasting ulcers and disfiguring scars, underscoring the need for comprehensive CL control strategies ...
Bahareh Abtahi‐Naeini +5 more
doaj +1 more source
Evaluation of farnesol orally and topically against experimental cutaneous leishmaniasis: In -vivo analysis. [PDF]
Sharma H +4 more
europepmc +1 more source
Experimental cutaneous leishmaniasis: transmission electron microscopy of the inoculation site
Tissue response against inoculation of Leishmania (Leishmania) amazonensis promastigotes in the hind footpad was quite different between two strains of mice: in BALB/c animals there was parasitism of perineurial cells by the 8th week post inoculation (WPI) and heavy parasitism of macrophages, as well as degenerated extracellular parasites close to ...
C, Vasconcellos, M N, Sotto
openaire +3 more sources
Immunity and immunosuppression in experimental visceral leishmaniasis
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner organs are affected. Since knowledge about immunity in experimental visceral leishmaniasis is poor, we present here a review on
Goto H., Lindoso J.A.L.
doaj
Leishmaniasis is a vector-borne infectious disease that affects many subtropical countries. Leishmania (L.) major and L. tropica are among the old-world causative agents and cause cutaneous leishmaniasis (CL).
Taha Masoudsinaki +11 more
doaj +1 more source
Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model. [PDF]
Lajevardi MS +7 more
europepmc +1 more source
MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis. [PDF]
Oliveira-Maciel D +10 more
europepmc +1 more source
Drug-containing hydrophobic dressings as a topical experimental therapy for cutaneous leishmaniasis
Cutaneous leishmaniasis (CL), a clinical condition caused mainly by Leishmania amazonensis in Brazil, is characterized by topical, painless ulcers. The current treatment, based on intravenous administration of pentavalent antimonials, presents low adherence by patients and may cause serious adverse effects, leading to the need for searching new ...
Viviane Pereira +5 more
openaire +3 more sources
Leishmaniasis is a complex disease caused by protozoan parasites of the genus Leishmania, which are transmitted by phlebotomine sand flies. The clinical manifestations of leishmaniasis are diverse, ranging from self-healing cutaneous lesions to fatal ...
Mahmoud Nateghi-Rostami +5 more
doaj +1 more source

